Metabolik ve Toksik Pediatrik Beyin Bozuklukları

Bahar Atasoy, (Bezmialem Vakıf Üniversitesi, Tıp Fakültesi, Radyoloji Anabilim Dalı, İstanbul, Türkiye)
Alpay Alkan (Adres Yazılmamış)
Türk Radyoloji Seminerleri
10 0
Yıl: 2019 Cilt: 7 Sayı: 3 Sayfa Aralığı: 306 - 323 Metin Dili: Türkçe DOI: 10.5152/trs.2019.801 İndeks Tarihi: 20-08-2020

Metabolik ve Toksik Pediatrik Beyin Bozuklukları

Öz:
-
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • [1]. Bindu PS, Sinha S, Taly AB, Christopher R, Kovoor JM. Cranial MRI in acute hyperammonemic encephalopathy. Pediatr Neurol 2009; 41: 139-42. [CrossRef]
  • [2]. Kojic J, Robertson PL, Quint DJ, Martin DM, Pang Y, Sundgren PC. Brain glutamine by MRS in a patient with urea cycle disorder and coma. Pediatr Neurol 2005; 32: 143-6. [CrossRef]
  • [3]. Razek AA, Abdalla A, Ezzat A, Megahed A, Barakat T. Minimal hepatic encephalopathy in children with liver cirrhosis: diffusion-weighted MR imagi g and proton MR spectroscopy of the brain. Neuroradiology 2014; 56: 885-91.[CrossRef]
  • [4]. Foerster BR, Conklin LS, Petrou M, Barker PB, Schwarz KB. Minimal hepatic encephalopathy in children: evaluation with MR spectroscopy. AJNR 2009; 30: 1610-3. [CrossRef]
  • [5]. Turkel SB, Miller CA, Guttenberg ME, Moynes DR, Hodgman JE. A clinical pathologic reappraisal of kernicterus. Pediatrics 1982; 69: 267-72.
  • [6]. Kim SY, Goo HW, Lim KH, Kim ST, Kim KS. Neonatal hypoglycaemic encephalopathy: diffusion-weighted imaging and proton MR spectroscopy. Pediatr Radiol 2006; 36: 144-8. [CrossRef]
  • [7]. Galllucci M, Limbucci N, Paonessa A, Caranci F. Reversible focal splenial lesions. Neuroradiology 2007; 49: 541-4. [CrossRef]
  • [8]. Renard D, Bonafe A, Heroum C. Transient lesion in the splenium of the corpus callosum after oral corticoid therapy. Eur J Neurol 2007; 14: 19-20. [CrossRef]
  • [9]. Yamamoto H, Natsume J, Kidokoro H, Ishihara N, Suzuki M, Tsuji T, et al. Clinical and neuroimaging fndings in children with posterior reversible encephalopathy syndrome. Eur J Paediatr Neurol 2015; 19: 672-8. [CrossRef]
  • [10]. Ergun T, Lakadamyali H, Yilmaz A. Recurrent posterior reversible encephalopathy syndrome in a hypertensive patient with end-stage renal disease. Diagn Interv Radiol 2008; 14: 182-5.
  • [11]. Habetz K, Ramakrishnaiah R, Raina SK, Fitzgerald RT, Hinduja A. Posterior reversible encephalopathy syndrome: a comparative study of pediatric versus adult patients. Pediatr Neurol 2016; 65: 45-51. [CrossRef]
  • [12]. McKinney AM, Short J, Truwit CL, McKinney ZJ, Kozak OS, SantaCruz KS, et al. Posterior reversible encephalopathy syndrome: incidence of atypical regions of involvement and imaging findings. AJR Am J Roentgenol 2007; 189: 904-12. [CrossRef]
  • [13]. Ozutemiz C, Roshan SK, Kroll NJ, Rykken JB, Ott F, McKinney AM. Concomitant acute toxic leukoencephalopathy and posterior reversible encephalopathy syndrome. J Neuroimaging 2018; 28: 535-41. [CrossRef]
  • [14]. McKinney AM, Kieffer SA, Paylor RT, SantaCruz KS, Kendi A, Lucato L. Acute toxic leukoencephalopathy: potential for reversibility clinically and on MRI with diffusion-weighted and FLAIR imaging. AJR Am J Roentgenol 2009; 193: 192-206 [CrossRef]
  • [15]. Özütemiz C, Roshan SK, Kroll NJ, Benson JC, Rykken JB, Oswood MC, et al. Acute toxic encephalopathy: etiologies, imaging findings and outcomes in 101 patients. AJNR Am J Neuroradiol 2019; 40: 267-75. [CrossRef]
  • [16]. Partap S, Russo S, Esfahani B, Yeom K, Mazewski C, Embry L, et al. A review of chronic leukoencephalopahy among survivors of childhood cancer. Pediatr Neurol 2019; 101: 2-10. [CrossRef]
  • [17]. Gupta R, Sharma J, Mod J. MRI spectrum in acute toxic and metabolic encephalopathies. ECR 2014; C-0492.
  • [18]. Perry A, Schmidt RE. Cancer therapy-associated CNS neuropathology: an update and review of the literature. Acta Neuropathol 2006; 111: 197-212. [CrossRef]
  • [19]. Pearl PL, Vezina LG, Saneto RP, McCarter R, Molloy-Wells E, Heffron A, et al. Cerebral MRI abnormalities associated with vigabatrin therapy. Epilepsia 2009; 50: 184-94. [CrossRef]
  • [20]. Schwartz RB, Bravo SM, Klufas RA, Hsu L, Barnes PD, Robson CD, et al. Cyclosporine neurotoxicity and its relationship to hypertensive encephalopathy: CT and MR findings in 16 cases. AJR Am J Roentgenol 1995; 165: 627-31. [CrossRef]
  • [21]. Kim E, Na DG, Kim EY, Kim JH, Son KR, Chang KH. MR imaging of metronidazole-induced encephalopathy: lesion distribution and diffusion-weighted imaging findings. AJNR Am J Neuroradiol 2007; 28: 1652-8. [CrossRef]
  • [22]. Gee P, Tallon C, Long N, Moore G, Boet R, Jackson S. Use of recreational drug 1,3 Dimethylamylamine (DMAA) [corrected] associated with cerebral hemorrhage. Ann Emerg Med 2012; 60: 431-4. [CrossRef]
  • [23]. De Roock S, Hantson P, Laterre PF, Duprez T. Extensive pallidal and white matter injury following cocaine overdose. Intensive Care Med 2007; 33: 2030-1. [CrossRef]
  • [24]. Geibprasert S, Gallucci M, Krings T. Addictive illegal drugs: structural neuroimaging. AJNR Am J Neuroradiol 2010; 31: 803-8. [CrossRef]
APA atasoy b, ALKAN A (2019). Metabolik ve Toksik Pediatrik Beyin Bozuklukları. , 306 - 323. 10.5152/trs.2019.801
Chicago atasoy bahar,ALKAN ALPAY Metabolik ve Toksik Pediatrik Beyin Bozuklukları. (2019): 306 - 323. 10.5152/trs.2019.801
MLA atasoy bahar,ALKAN ALPAY Metabolik ve Toksik Pediatrik Beyin Bozuklukları. , 2019, ss.306 - 323. 10.5152/trs.2019.801
AMA atasoy b,ALKAN A Metabolik ve Toksik Pediatrik Beyin Bozuklukları. . 2019; 306 - 323. 10.5152/trs.2019.801
Vancouver atasoy b,ALKAN A Metabolik ve Toksik Pediatrik Beyin Bozuklukları. . 2019; 306 - 323. 10.5152/trs.2019.801
IEEE atasoy b,ALKAN A "Metabolik ve Toksik Pediatrik Beyin Bozuklukları." , ss.306 - 323, 2019. 10.5152/trs.2019.801
ISNAD atasoy, bahar - ALKAN, ALPAY. "Metabolik ve Toksik Pediatrik Beyin Bozuklukları". (2019), 306-323. https://doi.org/10.5152/trs.2019.801
APA atasoy b, ALKAN A (2019). Metabolik ve Toksik Pediatrik Beyin Bozuklukları. Türk Radyoloji Seminerleri, 7(3), 306 - 323. 10.5152/trs.2019.801
Chicago atasoy bahar,ALKAN ALPAY Metabolik ve Toksik Pediatrik Beyin Bozuklukları. Türk Radyoloji Seminerleri 7, no.3 (2019): 306 - 323. 10.5152/trs.2019.801
MLA atasoy bahar,ALKAN ALPAY Metabolik ve Toksik Pediatrik Beyin Bozuklukları. Türk Radyoloji Seminerleri, vol.7, no.3, 2019, ss.306 - 323. 10.5152/trs.2019.801
AMA atasoy b,ALKAN A Metabolik ve Toksik Pediatrik Beyin Bozuklukları. Türk Radyoloji Seminerleri. 2019; 7(3): 306 - 323. 10.5152/trs.2019.801
Vancouver atasoy b,ALKAN A Metabolik ve Toksik Pediatrik Beyin Bozuklukları. Türk Radyoloji Seminerleri. 2019; 7(3): 306 - 323. 10.5152/trs.2019.801
IEEE atasoy b,ALKAN A "Metabolik ve Toksik Pediatrik Beyin Bozuklukları." Türk Radyoloji Seminerleri, 7, ss.306 - 323, 2019. 10.5152/trs.2019.801
ISNAD atasoy, bahar - ALKAN, ALPAY. "Metabolik ve Toksik Pediatrik Beyin Bozuklukları". Türk Radyoloji Seminerleri 7/3 (2019), 306-323. https://doi.org/10.5152/trs.2019.801
Sayfa Oluşturulma Tarihi
23-04-2024 12:58

İLETİŞİM

TÜBİTAK ULAKBİM TR Dizin

Yüzüncüyıl, İşçi Blokları Mahallesi

Muhsin Yazıcıoğlu Caddesi No:51/C

06530 Çankaya / ANKARA +90 (312) 298 92 00

trdizin@tubitak.gov.tr

TÜBİTAK ULAKBİM Ulusal Akademik Ağ ve Bilgi Merkezi Cahit Arf Bilgi Merkezi © Tüm Hakları Saklıdır. Gizlilik Politikası Kullanım Şartları